Innovative drug concept fluctuates and rebounds; Nearshore Protein rises over 6%, continuing to hit a record high.

In early trading, the innovative drug concept fluctuated and rebounded, with Nearshore Protein rising more than 6%, continuing to hit a record high. Earlier, Jinyao Pharmaceutical hit its second consecutive limit-up, while Baihua Pharmaceutical, Kanghong Pharmaceutical, Innostellar, InventisBio, and Betta Pharmaceuticals followed the gains.